Business
Allergan Aesthetics Announces Expansion of SKINVIVE by JUVÉDERM® into 35 New Markets, Reinforcing its Commitment to Advancing Global Skin Quality
Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced the roll-out of SKINVIVE by JUVÉDERM® in 35 additional markets this year bringing the total to 57 globally in 2025. This expansion underscores Allergan Aesthetics' global strategic commitment to enhancing skin quality worldwide.
About this update from Abbvie Inc.
[{"type":"list","items":[{"val":[{"type":"text","content":"SKINVIVE® to launch in 35 additional markets worldwide from September taking the total to 57 international launches in 2025.","length":124,"tagName":"p"}]},{"val":[{"type":"text","content":"Research highlights 94% of people want to improve facial skin quality1*, with deep hydration valued across all ages worldwide2.","length":127,"tagName":"p"}]},{"val":[{"type":"text","content":"SKINVIVE® is the longest lasting hydrating injectable on the market, delivered in one treatment.3,4,†","length":101,"tagName":"p"}]},{"val":[{"type":"text","content":"AMWC Dubai agenda spotlights multimodal approach to skin quality, following the launch of AA Signature™ to enhance outcomes with Allergan Aesthetics portfolio.","length":159,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":511,"olType":false},{"type":"text","content":"IRVINE, Calif., Sept. 23, 2025 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced the roll-out of SKINVIVE by JUVÉDERM® in 35 additional markets this year bringing the total to 57 globally in 2025. This expansion underscores Allergan Aesthetics' global strategic commitment to enhancing skin quality worldwide. ","length":348,"tagName":"p"},{"type":"text","content":"SKINVIVE® is an advanced skincare solution for healthy-looking skin, delivering long-lasting hydration and smoothness to the facial area with a single treatment.3,§,‖","length":171,"tagName":"p"},{"type":"text","content":""This extensive rollout marks an exciting new era for Allergan Aesthetics, placing a greater emphasis on skin quality," said Mark Wilson, SVP, International Allergan Aesthetics. "As we observe a shift in consumer behavior towards skin health-focused solutions, we're committed to evolving our injectable portfolio. Through introducing innovative injection techniques, new treatment approaches with AA Signature™, and strategic product launches worldwide, our mission is to help empower practitioners deliver the best possible results for their patients."","length":578,"tagName":"p"},{"type":"text","content":"The global skin quality market is worth $5.2B5¶, with aesthetic patients increasingly prioritizing health, wellness and a more natural look rather than overt facial changes.","length":178,"tagName":"p"},{"type":"text","content":"Global...